Clinical Trials · NCT06352411
A Study to Test How BI 456906 is Taken up in the Blood of People With and Without Kidney Problems
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Boehringer Ingelheim
- Enrollment
- 42
- Start date
- May 2024
- Locations
- 2 sites, Germany
- Primary endpoint
- Area under the concentration-time curve of BI 456906 in plasma over the time interval from 0 to the last quantifiable data point (AUC0-tz)